# Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder

> **NCT06444256** · PHASE2 · RECRUITING · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 20 (estimated)

## Conditions studied

- Stimulant Use Disorder

## Interventions

- **DRUG:** SUVO
- **DRUG:** TAU

## Key facts

- **NCT ID:** NCT06444256
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-25
- **Primary completion:** 2027-01-30
- **Final completion:** 2027-01-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06444256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06444256, "Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06444256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*